Related Experiment Video

Updated: Aug 6, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Manufacture of antithymocyte globulin (ATGAM) for clinical trials

W J Wechter, J W Nelson, R J Perper

    Transplantation
    |October 1, 1979
    PubMed

    Methods are described for preparing large amounts of horse anti-human thymocyte globulin (ATG, ATGAM; The Upjohn Company) for clinical use. These methods have been used since 1968 to provide material for clinical trials. Characteristics of 40 lots of ATG are summarized.

    More Related Videos

    A GMP-Compliant Procedure for the Generation of Gene-Modified T cells06:47

    A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

    Published on: October 6, 2023

    Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor06:18

    Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

    Published on: August 18, 2023

    Related Concept Videos

    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...